Electronegative ApoCIII-Rich HDL promotes cellular damage and vascular aging

30 August 2024 (08:00 - 17:30)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Wen-Li Hsu

National Health Research Institute, Yunlin (Taiwan)

6 More presentations in this session

Presentation thumbnail

Rare genetic variants in LDLR, APOB, and PCSK9 are associated with aortic stenosis

Mr S. Jurgens (Amsterdam, NL)

Abstract Slides Video

Presentation thumbnail

Lipidomics-based deep learning algorithms can enhance prediction of obstructive coronary artery disease

Doctor E. Karagiannidis (Thessaloniki, GR)

Abstract Slides Video

Presentation thumbnail

Peroxisome proliferator-activated receptor gamma regulates interleukin-6 induced lipoprotein(a) gene expression in human HepG2 cells

Doctor T. Harb (Baltimore, US)

Abstract Slides Video

Presentation thumbnail

Linking antibody against apolipoprotein A-1 to metabolic dysfunction-associated steatohepatitis in mice

Doctor S. Pagano (Geneva, CH)

Abstract Slides Video

Presentation thumbnail

Beyond LDL-cholesterol: effects of alirocumab on the human apolipoproteome

Mr L. Schmidt (Vienna, AT)

Abstract Slides Video

Access the full session

Session thumbnail

Lipids: new pathophysiological and therapeutic insights

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024

You may be interested in

Congress Presentation

Electronegative H5 HDL: an apo(a)-containing HDL that damages neuronal DNA by potentially disrupting the BBB

Congress Presentation

Association of HDL composition and functionality with markers of subclinical vascular disease in individuals with extremely high HDL

Congress Presentation

High-sensitivity CRP to HDL-C ratio as a novel inflammatory-lipid biomarker for mortality risk prediction: a prospective population-based cohort study

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources